FrancesG50
Member
According to Google's AI there looks to be a promising drug,
"In a recent study, it was presented a new form of insulin formulation (AKS-267c) that would only require once-weekly injections. The active molecule in this formulation is a fusion of synthetic insulin and the feline fragment crystallizable (Fc) region of immunoglobulins."
Is this drug out of the testing phase yet? Did it fail to deliver as promised? Wondering if anyone knows of anything about it.
Thanks for any info you have.
"In a recent study, it was presented a new form of insulin formulation (AKS-267c) that would only require once-weekly injections. The active molecule in this formulation is a fusion of synthetic insulin and the feline fragment crystallizable (Fc) region of immunoglobulins."
Is this drug out of the testing phase yet? Did it fail to deliver as promised? Wondering if anyone knows of anything about it.
Thanks for any info you have.